12276 Federal Register / Vol. 68, No. 49 / Thursday, March 13, 2003 / Proposed Rules ENVIRONMENTAL PROTECTION AGENCY 40 CFR Part 439 [ FRL   7462   7]

Effluent Limitations Guidelines, Pretreatment Standards, and New Source Performance Standards for the Pharmaceutical Manufacturing Point Source Category; Proposed Rule AGENCY: Environmental Protection Agency. ACTION: Proposed rule.

SUMMARY: The Environmental Protection Agency ( EPA) is proposing to amend certain provisions of the effluent guidelines for the Pharmaceutical Manufacturing Point Source Category, which were published on September 21, 1998 ( 63 FR 50424). First, EPA is clarifying the date on which a discharger subject to the New Source Performance Standards ( NSPS) and the Pretreatment Standards for New Sources ( PSNS) would be subject to effluent limitations and pretreatment standards established in the 1998 regulation. Second, this rule re establishes a minimum concentration for the maximum monthly average BOD5 limitation that EPA inadvertently omitted from the Best Practicable Control Technology ( BPT) requirements in two subcategories of the 1998 regulation. Next, the amendments correct an error in EPA's pass through analysis prepared in support of the 1998 rule and, as a result, methyl Cellosolve ( 2 methoxyethanol) from the pretreatment standards in two subcategories and from Appendix A, Table 2, `` Surrogate Parameters for Indirect Dischargers.'' Finally, the Agency is making other non substantive editorial and format changes such as removing redundancies, and adding definitions.

DATES: Comments must be received by May 12, 2003. Comments postmarked after this date may not be considered. ADDRESSES: Comments may be submitted electronically, by mail, or through hand delivery/ courier. Please mail comments to the Water Docket, Environmental Protection Agency, Mailcode: 4101T, 1200 Pennsylvania Avenue, NW., Washington, DC 20460 or submit them electronically to http:// www. epa. gov/ edocket. Send either to the Attention of Docket ID No. OW   2003   0007. See section I. C. of the SUPPLEMENTARY INFORMATION section for more information on submitting comments.

FOR FURTHER INFORMATION CONTACT: Dr. Frank Hund, U. S. EPA Office of Water by phone at ( 202) 566   1027 or by e mail at hund. frank@ epa. gov.

SUPPLEMENTARY INFORMATION:

I. General Information A. Regulated Entities Entities potentially regulated by this action include facilities of the following types that discharge pollutants directly or indirectly to U. S. waters.

Category Examples of regulated entities SIC ( NAICS) code Industry ........................... Facilities that generate process wastewater from the manufacture of pharmaceutical products and/ or pharmaceutical intermediates by fermentation, extraction chemical synthesis and/ or mixing, compounding and formulating. 2833, R834, 2836 ( 2834   04, 2834   98).

This table is not intended to be exhaustive, but rather provides a guide for readers regarding entities likely to be regulated by this action. This table lists the types of entities that EPA is now aware could potentially be regulated by this action. Other types of entities not listed in the table could also be regulated. To determine whether your facility is regulated by this action, you should carefully examine the definitions and applicability criteria in § § 439.10, 439.20, 439.30, 439.40 and 439.50 of title 40 of the Code of Federal Regulations. If you have questions regarding the applicability of this action to a particular entity, consult the person listed in the preceding FOR FURTHER INFORMATION CONTACT section.

B. How Can I Get Copies of This Document and Other Related Information?

1. Docket. EPA has established an official public docket for this action under Docket ID No. OW   2003   0007. The official public docket consists of the documents specifically referenced in this action, any public comments received, and other information related to this action. The official public docket is the collection of materials that is available for public viewing at the Water Docket in the EPA Docket Center, ( EPA/ DC) EPA West, Room B102, 1301 Constitution Ave., NW., Washington, DC. The EPA Docket Center Public Reading Room is open from 8: 30 a. m. to 4: 30 p. m., Monday through Friday, excluding legal holidays. The telephone number for the Public Reading Room is ( 202) 566   1744, and the telephone number for the Water Docket is ( 202) 566   2426. For access to docket materials, please call ahead to schedule an appointment. Every user is entitled to copy 100 pages before incurring a charge. The Docket may charge 15 cents a page for each page over the 100 page limit. 2. Electronic Access. You may access this Federal Register document electronically through the EPA Internet under the `` Federal Register'' listings at http:// www. epa. gov/ fedrgstr/. An electronic version of the public docket is available through EPA's electronic public docket and comment system, `` EPA Dockets.'' You may use EPA Dockets at http:// www. epa. gov/ edocket/ to submit or view public comments, access the index listing of the contents of the official public docket, and to access those documents in the public docket that are available electronically. Once in the system, select `` search,'' then key in the appropriate docket identification number. Certain types of information will not be placed in the EPA Dockets. Information claimed as confidential business information ( CBI) and other information whose disclosure is restricted by statute, which is not included in the official public docket, will not be available for public viewing in EPA's electronic public docket. EPA's policy is that copyrighted material will not be placed in EPA's electronic public docket but will be available only in printed, paper form in the official public docket. To the extent feasible, publicly available docket materials will be made available in EPA's electronic public docket. When a document is selected from the index list in EPA Dockets, the system will identify whether the document is available for viewing in EPA's electronic public docket. Although not all docket materials may be available electronically, you may still access any of the publicly available docket materials through the docket facility identified in section I. B. 1. EPA intends to work towards providing electronic access to all of the publicly available docket materials through EPA's electronic public docket.

VerDate Jan< 31> 2003 18: 44 Mar 12, 2003 Jkt 200001 PO 00000 Frm 00001 Fmt 4701 Sfmt 4702 E:\ FR\ FM\ 13MRP3. SGM 13MRP3 12277 Federal Register / Vol. 68, No. 49 / Thursday, March 13, 2003 / Proposed Rules For public commenters, it is important to note that EPA's policy is that public comments, whether submitted electronically or in paper, will be made available for public viewing in EPA's electronic public docket as EPA receives them and without change, unless the comment contains copyrighted material, CBI, or other information whose disclosure is restricted by statute. When EPA identifies a comment containing copyrighted material, EPA will provide a reference to that material in the version of the comment that is placed in EPA's electronic public docket. The entire printed comment, including the copyrighted material, will be available in the public docket. Public comments submitted on computer disks that are mailed or delivered to the docket will be transferred to EPA's electronic public docket. Public comments that are mailed or delivered to the Docket will be scanned and placed in EPA's electronic public docket. Where practical, physical objects will be photographed, and the photograph will be placed in EPA's electronic public docket along with a brief description written by the docket staff. For additional information about EPA's electronic public docket visit EPA Dockets online or see 67 FR 38102, May 31, 2002.

C. How and to Whom Do I Submit Comments? You may submit comments electronically, by mail, or through hand delivery/ courier. Please submit with your comments any references cited in your comments. To ensure proper receipt by EPA, identify the appropriate docket identification number in the subject line on the first page of your comment. Please ensure that your comments are submitted within the specified comment period. Comments received after the close of the comment period will be marked `` late.'' EPA is not required to consider these late comments; however, late comments may be considered if time permits. If you wish to submit CBI or information that is otherwise protected by statute, please follow the instructions in section I. D. Do not use EPA Dockets or e mail to submit CBI or information protected by statute. 1. Electronically. If you submit an electronic comment as prescribed below, EPA recommends that you include your name, mailing address, and an e mail address or other contact information in the body of your comment. Also include this contact information on the outside of any disk or CD   ROM you submit, and in any cover letter accompanying the disk or CD   ROM. This ensures that you can be identified as the submitter of the comment and allows EPA to contact you in case EPA cannot read your comment due to technical difficulties or needs further information on the substance of your comment. EPA's policy is that EPA will not edit your comment, and any identifying or contact information provided in the body of a comment will be included as part of the comment that is placed in the official public docket, and made available in EPA's electronic public docket. If EPA cannot read your comment due to technical difficulties and cannot contact you for clarification, EPA may not be able to consider your comment. i. EPA Dockets. Your use of EPA's electronic public docket to submit comments to EPA electronically is EPA's preferred method for receiving comments. Go directly to EPA Dockets at http:// www. epa. gov/ edocket, and follow the online instructions for submitting comments. To access EPA's electronic public docket from the EPA Internet Home Page, select `` Information Sources,'' `` Dockets,'' and `` EPA Dockets.'' Once in the system, select `` search,'' and then key in Docket ID No. OW   2003   0007. The system is an `` anonymous access'' system, which means EPA will not know your identity, e mail address, or other contact information unless you provide it in the body of your comment. ii. E mail. Comments may be sent by electronic mail ( e mail) to OW   Docket@ epa. gov, Attention Docket ID No. OW   2003   0007. In contrast to EPA's electronic public docket, EPA's email system is not an `` anonymous access'' system. If you send an e mail comment directly to the Docket without going through EPA's electronic public docket, EPA's e mail system automatically captures your e mail address. E mail addresses that are automatically captured by EPA's e mail system are included as part of the comment that is placed in the official public docket, and made available in EPA's electronic public docket. iii. Disk or CD   ROM. You may submit comments on a disk or CD   ROM that you mail to the mailing address identified in section 1. C. 2. These electronic submissions will be accepted in Word Perfect or ASCII file format. Avoid the use of special characters and any form of encryption. 2. By Mail. Send an original and three ( 3) copies of your comments to the Water Docket, Environmental Protection Agency, Mail Code 4101T, 1200 Pennsylvania Ave., NW., Washington, DC 20460, Attention Docket ID No. OW   2003   0007. 3. By Hand Delivery or Courier. Deliver your comments to: Water Docket, EPA Docket Center, EPA West, Room B102, 1301 Constitution Ave., NW., Washington, DC, Attention Docket ID No. OW   2003   0007. Such deliveries are only accepted during the Docket's normal hours of operation as identified in section I. B. 1.

D. How Should I Submit CBI to the Agency? Do not submit information that you consider to be CBI electronically through EPA's electronic public docket or by e mail. Send information identified as CBI by mail only to the following address: Office of Science and Technology, Mail Code 4303T, U. S. Environmental Protection Agency, 1200 Pennsylvania Ave., NW., Washington, DC 20460, Attention: Frank Hund, Docket ID No. OW   2003   0007. You may claim information that you submit to EPA as CBI by marking any part or all of that information as CBI ( if you submit CBI on disk or CD   ROM, mark the outside of the disk or CD   ROM as CBI and then identify electronically within the disk or CD   ROM the specific information that is CBI). Information so marked will not be disclosed except in accordance with procedures set forth in 40 CFR part 2. In addition to one complete version of the comment that includes any information claimed as CBI, a copy of the comment that does not contain the information claimed as CBI must be submitted for inclusion in the public docket and EPA's electronic public docket. If you submit the copy that does not contain CBI on disk or CD   ROM, mark the outside of the disk or CD   ROM clearly that it does not contain CBI. Information not marked as CBI will be included in the public docket and EPA's electronic public docket without prior notice. If you have any questions about CBI or the procedures for claiming CBI, please consult the person identified in the FOR FURTHER INFORMATION CONTACT section.

II. Discussion of Direct Final Rulemaking In the `` Rules and Regulations'' section of today's Federal Register, EPA is promulgating these revisions as a direct final rule without prior proposal because we view them as noncontroversial revisions and anticipate no adverse comment. We have explained our reasons for these revisions in the preamble to the direct final rule. If we receive no adverse comment, we will not take further VerDate Jan< 31> 2003 18: 25 Mar 12, 2003 Jkt 200001 PO 00000 Frm 00002 Fmt 4701 Sfmt 4702 E:\ FR\ FM\ 13MRP3. SGM 13MRP3 12278 Federal Register / Vol. 68, No. 49 / Thursday, March 13, 2003 / Proposed Rules action on this proposed rule. If we receive adverse comment, we will withdraw the direct final rule or portions thereof, and the direct final rule or portions thereof will not take effect. We will address all public comments in a subsequent final rule based on this action. We will not institute a second comment period on this action. Any parties interested in commenting must do so at this time. III. Related Acts of Congress, Executive Orders, and Agency Initiatives For the various statutes and Executive Orders that require findings for rulemaking, EPA incorporates the findings from the direct final rule into this companion proposal for the purpose of providing public notice and opportunity for comment. List of Subjects in 40 CFR Part 439 Environmental protection, Drugs, Reporting and recordkeeping requirements, Waste treatment and disposal, Water pollution control.

Dated: February 28, 2003. Christine Todd Whitman, Administrator. [ FR Doc. 03   5715 Filed 3   12   03; 8: 45 am]

BILLING CODE 6560   50   P VerDate Jan< 31> 2003 18: 25 Mar 12, 2003 Jkt 200001 PO 00000 Frm 00003 Fmt 4701 Sfmt 4702 E:\ FR\ FM\ 13MRP3. SGM 13MRP3


EPA REGISTRATION DIVISION - COMPANY NOTICE OF FILING FOR PESTICIDE PETITIONS

Docket ID Number:  EPA-HQ-OPP-2011-0985

EPA Registration Division Contact: Sidney Jackson<PHONE_NUMBER>)

Pesticide Petition Number: 1E7942

	EPA has received a pesticide petition (PP) 1E7942 from the  Interregional Research Project Number 4 (IR-4), IR-4 Project Headquaters, 500 College Road East, Suite 201W, Princeton, New Jersey, 08540, proposing, pursuant to section 408(d) of the Federal Food, Drug, and Cosmetic Act (FFDCA), 21 U.S.C. 346a(d), to amend 40 CFR part 180 by establishing a tolerance for residues of the combined residues of the insecticide flonicamid [N-(cyanomethyl)-4-(trifluoromethyl)-3-pyridinecarboxamide]and its metabolites TFNA [4-trifluoromethylnicotinic acid], TFNA-AM [4-trifluoromethylnicotinamide] and TFNG [N-(4-trifluoromethylnicotinoyl)glycine] in or on the raw agricultural commodities: Berry, low growing, subgroup 13-07G at 1.4 parts per million (ppm), Cucumber at 1.3 ppm and Rapeseed subgroup 20A at 1.5 ppm. EPA has determined that the petition contains data or information regarding the elements set forth in section 408 (d)(2) of  FDDCA; however, EPA has not fully evaluated the sufficiency of the submitted data at this time or whether the data supports granting of the petition. Additional data may be needed before EPA rules on the petition.

A. Residue Chemistry

	1. Plant metabolism. Wheat, potato and peach metabolism studies were conducted using [14C]-pyridyl-flonicamid.  The metabolic profile was similar for all three matrices.  The major metabolites for the various crops were:  TFNA in peach, TFNA and TFNG in potato and TFNG in wheat. The metabolism of flonicamid in plants shows the main pathway of metabolism involves hydrolysis of -CN and BCONH2 functional groups in the molecule.  The metabolism of flonicamid in plants is well understood.

	2. Analytical method. Analytical methodology has been developed to determine the residues of flonicamid and its three major plant metabolites, TFNA, TFNG, and TFNA-AM in various crops.   The residue analytical method for the majority of crops includes an initial extraction with acetonitrile (ACN)/deionized (DI) water, followed by a liquid-liquid partition with ethyl acetate.  The residue method for wheat straw is similar, except that a C18 solid phase extraction (SPE) is added prior to the liquid-liquid partition.  The final sample solution is quantitated using a liquid chromatograph (LC) equipped with a reverse phase column and a triple quadruple mass spectrometer (MS/MS).

	3. Magnitude of residues. Residue data were collected on Berry, low growing, subgroup 13-07G; greenhouse cucumber; and Rapeseed subgroup 20A during field trials.  Maximum total residues for strawberry, representative of low growing berry crops (total of 8 field trials) ranged from 0.140 to 0.768 parts per million (ppm) strawberry samples.  Maximum total residues for greenhouse cucumber as a separate commodity (total of 4 field trials) ranged from 0.076 to 0.76 ppm.  Maximum total residues for canola, representative of rapeseed (total of 9 field trials) ranged from 0.027 to 0.855 ppm.

In one trial, samples were processed into canola meal and oil.  Processed canola samples (meal and oil) had lower residues than the unprocessed canola seed that had been treated at the same rate, thus it is demonstrated that flonicamid does not concentrate in processed canola matrices.

B. Toxicological Profile

	1. Acute toxicity.  A battery of acute toxicity studies was conducted which placed flonicamid technical in Toxicity Category III for oral LD50, Category IV for dermal LD50, inhalation LC50, dermal irritation, and eye irritation. Flonicamid technical is not a dermal sensitizer.  In an acute neurotoxicity study, the no observed adverse effect levels (NOAELs) for neurotoxicity were 600 mg/kg in males and 1000 mg/kg in female (highest doses tested).  The systemic NOAELs were 600 mg/kg in males and 300 mg/kg in females.

	2. Genotoxicity.  Flonicamid technical did not cause mutations in the bacterial reverse mutation or mouse lymphoma tests with or without metabolic activation, chromosome damage in the mouse micronucleus or cytogenetics tests with and without metabolic activation, an increase in DNA damage in the comet assay or in an in vivo rat unscheduled DNA synthesis (UDS) study.  Based on the weight of evidence, it is concluded that flonicamid technical is not genotoxic.

	3. Reproductive and developmental toxicity.  A developmental toxicity study in rats resulted in the maternal and developmental no observed effect levels (NOELs) of 100 mg/kg/day.  The maternal lowest observed effect level (LOEL) was 500 mg/kg/day based on the treatment-related effects observed on the liver and kidney of the dams in the highest dose group.  The developmental lowest observed effect level (LOEL) was 500 mg/kg/day based on  incidences of fetal skeletal variations seen only at maternally toxic doses of 500 mg/kg/day.
In the rabbit developmental toxicity study, the maternal and developmental NOELs were 7.5 mg/kg/day and > 25 mg/kg/day (HDT), respectively.  The maternal LOEL was 25 mg/kg/day based on decreased body weights, body weight gains and food consumption.  No adverse effects on the fetuses were observed at the highest dose.
In the multigeneration rat reproduction study, the NOAEL was 50 ppm for parental animals (3.7 and 4.4 mg/kg/day, respectively, for males and females) and 300 ppm for their offspring (22.3 and 26.5 mg/kg/day, respectively, for males and females).  The effects at the highest dose of 1800 ppm included the following: increased kidney weights and gross and histopathological alterations in the kidney.  Findings noted in the top dose females included delayed vaginal opening and increased liver, kidney and spleen weights in the F1 generation and reduced ovary and adrenal weights in the parental generation and decreased uterine weights in the F1 female weanlings.  There was an increase in the FSH and LH levels in F1 females tested for these endpoints.  These findings did not affect the reproductive performance or survival of offspring in the study.

	4. Subchronic toxicity. The no observed adverse effect level (NOAEL) for flonicamid technical in the rat 28-day dermal toxicity study was 1000 mg/kg/day, which was the highest dose tested.
In a 90-day rat feeding study the NOAEL was established at 200 ppm (12.11 mg/kg/day) for males and 1000 ppm (72.3 mg/kg/day) for females.  The LOAELs were 1000 ppm (60.0 mg/kg/day) for males and 5000 ppm (340 mg/kg/day) for females based on effects on hematology, triglycerides, and pathology in the liver and kidney.
   In a 13-week mouse study, the NOAEL was 100 ppm (15.25 mg/kg/day in males and 20.1 mg/kg/day in females).  The LOAEL is 1000 ppm (153.9 mg/kg/day in males and 191.5 mg/kg/day in females) based on hematology effects and changes in glucose, creatinine, bilirubin, sodium, chloride and potassium levels, increased liver and spleen weights and histopathology findings in the bone marrow, spleen and kidney.
   In a subchronic toxicity study in dogs with capsule administration, the NOAEL was 8 mg/kg/day in males and 20 mg/kg/day in females based on findings of severe toxicity at a dose exceeding the maximum tolerated dose; symptoms included collapse, prostration and convulsions leading to early sacrifice at the LOAEL of 50 mg/kg/day.
   In a subchronic neurotoxicity study in rats, the NOAEL for dietary administration was 200 ppm for males and 1000 ppm for females (13 mg/kg/day in males and 81 mg/kg/day in females).  The LOAEL was 1000 and 10,000 ppm (67 and 722 mg/kg/day) in males and females, respectively (highest dose tested) based on decreased motor activity, body weight and food consumption effects.

   	5. Chronic toxicity. In the chronic dog study with administration via using capsules, the NOEL was 8 mg/kg/day.  The LOAEL was 20 mg/kg/day based on reduced body weights in females and effects on the circulating red blood cells.

   In a rat 24-month combined chronic and oncogenicity study, flonicamid technical was not carcinogenic in rats.  The NOAEL was 200 ppm (7.32 mg/kg/day) for males and 1000 ppm (44.1 mg/kg/day) for females. The LOAEL was 1000 ppm for males and 5000 ppm for females based on histopathology in the kidney, hematology effects, hepatic effects including changes in biochemical parameters, increased organ weights, and histopathological changes.  Atrophy of striated muscle fibers, cataract and retinal atrophy observed in the high dose females were considered to be due to acceleration of spontaneous age-related lesions.
   In the 18-month mouse study, effects were observed in the lung, liver, spleen and bone marrow at 250 ppm or higher.  Findings included centrilobular hepatocellular hypertrophy, extramedullary hematopoiesis and pigment deposition in the spleen and decreased cellularity (hypocellularity) in the bone marrow.  There were statistically significant increases in the incidence of alveolar/bronchiolar adenomas in both sexes of treated groups with hyperplasia/hypertrophy of epithelial cells in terminal bronchioles.  There was a statistically significant increase in the incidence of alveolar/bronchiolar carcinomas in males at 750 ppm and 2250 ppm and in females at 2250 ppm only.  These effects in the lungs of mice were not life-threatening as most of effects were observed at the terminal sacrifice and there was no effect of treatment on mortality in the study.  A no observed adverse effect level (NOAEL) could not be determined from the dose levels administered.  Mechanism-of-action studies have indicated that the lung effects are unique to the mouse and are not likely to translate to other species including the rat.  A second 18-month mouse study was conducted in CD-1 mice at dose levels ranging from 10 to 250 ppm to establish a NOAEL for hyperplasia/hypertrophy of epithelial cells in terminal bronchioles and for the incidence of alveolar/bronchiolar adenomas and carcinomas in both sexes.  There was a statistically significant increase in the incidence of alveolar/bronchiolar adenomas in males at 250 ppm.   In females, there was no statistically significant increase in the incidence of pulmonary neoplastic lesions at any dose level.  The incidence of hyperplasia/hypertrophy of epithelial cells lining the terminal bronchioles of the lungs was statistically increased at 250 ppm in both sexes.  There were no treatment-related increases in neoplastic or non-neoplastic lesions at dose levels of 80 ppm or lower in either sex.  The NOAELs were 10.0 and 11.8 mg/kg body weight/day for males and females, respectively.  This study confirmed a threshold for these effects at 80 ppm.  Flonicamid technical was not carcinogenic in the rat.

   	6. Animal metabolism. Rat, goat and poultry metabolism studies were conducted using [[14]C]-pyridyl-flonicamid.  The majority of the dose was rapidly excreted.  Flonicamid was a major component of rat urine 48 hours after dosing.  TFNA-AM was the major metabolite found in rats (urine), goats (milk and tissues) and in laying hens (tissues and eggs).  TFNG was found between 8 - 24% of the total radioactive residue (TRR) in the livers of rats sacrificed at intervals between 0.5 - 6 hours after dosing.  The liver samples at these time intervals had [14]C-residues of 2.3% - 4.6% of the dose.  TFNA was not a major component in animal tissues.  The metabolism of flonicamid in animals shows the main pathway of metabolism involves hydrolysis of -CN and -CONH2 functional groups in the molecule, identical to plant metabolism.  The main metabolic reactions were hydrolysis of cyano to the amide function and ring hydroxylation.  In rats flonicamid was further metabolized by several routes, including nitrile hydrolysis, amide hydrolysis, N-oxidation, and hydroxylation of the pyridine ring, leading to multiple metabolites. The metabolism of flonicamid in animals is well understood.

   	7. Metabolite toxicology. The main metabolites of flonicamid were examined in acute oral toxicity studies in rats and bacterial reverse mutation tests.  All the metabolites were less toxic than flonicamid and not mutagenic.

   	8. Endocrine disruption.  No special studies investigating potential estrogenic or other endocrine effects of flonicamid have been conducted.  Some suggestions of possible endocrine effects were reported at the highest dose tested (1800 ppm) in the multi-generation reproduction study which showed increased FSH and LH levels, a delay in the time to vaginal opening in the F1 generation, and reduced ovary and adrenal weights in the parental generation.  However, there were no effects on reproductive performance or survival of the offspring in the study.  At levels that are expected to be found in the environment, flonicamid will not cause any endocrine-related effects.

   C. Aggregate Exposure

      1. Dietary exposure.   Exposure assessments were conducted to evaluate the potential risk due to dietary exposure of the U.S. population to residues of flonicamid.

For acute dietary exposure, an Acute Reference Dose (aRfD) is not identified for flonicamid since there was no evidence of initial acute effects in the acute toxicity studies.  Furthermore, endpoints from the acute neurotoxicity and developmental toxicity studies, as well as from other short- and long-term studies, were not appropriate for assessing acute dietary risk.
For chronic dietary exposure, the chronic reference dose (cRfD) is 0.04 mg/kg/day, based on the NOEL of 3.7 mg/kg/day from the 2-generation reproduction toxicity rat study
and a 100-fold uncertainty factor.  The chronic population adjusted dose (cPAD) is also 0.04 mg/kg/day since the FQPA safety factor for flonicamid is 1x.

	i. Food.  Potential dietary exposures from food were estimated using the proposed tolerances for all crops using the Dietary Exposure Evaluation Model (DEEM-FCID[TM])  and percent crop treated of 100%.  The following raw agricultural commodities were included:  head and stem brassica, leafy brassica greens, leafy vegetables (except brassica), cotton, tuberous and corm vegetables, fruiting vegetables, cucurbits, stone fruits, pome fruits, vegetable root crops except sugarbeet, radish tops, turnip greens, hops, okra, berry, low growing, greenhouse cucumber, canola seed and resulting secondary residues in meat, milk, poultry and eggs.

Chronic dietary exposure estimates resulted in an estimated exposure for the general U.S. population of 0.004240 mg/kg bwt/day.  This exposure corresponds to 10.6% of the cPAD of 0.04 mg/kg bwt/day.  The highest exposure estimate calculated was for the subgroup children, 1-2 years.  This exposure was determined to be 0.009081 mg/kg bwt/day (22.7% of the cPAD).

	ii. Drinking water. Since flonicamid is intended for application outdoors to field grown crops, the potential exists for parent and/or metabolites to reach ground or surface water that may be used for drinking water.  An estimated concentration of 1.5 ppb of flonicamid in drinking water was provided by EFED for crops uses in 2007. This value was used in the chronic DEEM dietary assessment.

	2. Non-dietary exposure. There are currently no residential uses of flonicamid registered or pending action that need to be added to the total risk from exposure.

D. Cumulative Effects

	Unlike other pesticides for which EPA has followed a cumulative risk approach based on a common mechanism of toxicity, EPA has not made a common mechanism of toxicity finding as to flonicamid and any other substances, and flonicamid does not appear to produce a toxic metabolite produced by other substances.  EPA concluded that the evidence did not support a finding of common mechanism for flonicamid and other substances.

E. Safety Determination

	1. U.S. population. Using conservative exposure assessment analyses, the chronic dietary exposure estimates for the various population groups are well below the cPAD of 0.04 mg/kg bw/day.  Based on this information, it can be concluded that there is reasonable certainty that no harm will result from acute or chronic exposure to flonicamid.

	2. Infants and children. Based on the available developmental and reproductive data on flonicamid, it can be concluded that reliable data support use of the standard 100-fold uncertainty factor, and that an additional uncertainty factor is not needed to protect the safety of infants and children under the FQPA. Although the reproduction study indicated signs of toxicity to some reproductive organs/systems at the high dose of 1800 ppm in the diet, other signs of toxicity such as effects on the kidney accompanied these; there were no effects observed at a dose level of 300 ppm.  There were no effects on reproduction or survival at any dose level.  Since chronic aggregate exposure assessments are well below the cPAD, there is reasonable certainty that no harm will result to infants and children from aggregate exposure to flonicamid residues.

F. International Tolerances

Canada has established MRLs for flonicamid and its metabolites on head and stem brassica, leafy brassica greens, leafy vegetables (except brassica), tuberous and corm vegetables, fruiting vegetables, cucurbits, stone fruits, pome fruits, vegetable root crops except sugarbeet, radish tops, turnip greens, hops, and resulting secondary residues in meat, milk, poultry and eggs.

There are no Mexican residue limits or Codex MRLs for the insecticide flonicamid and its metabolites TFNA, TFNA-AM and TFNG.


[Federal Register Volume 74, Number 102 (Friday, May 29, 2009)]
[Notices]
[Pages 25752-25753]
[FR Doc No: E9-12493]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2009-N-0215]

Agency Information Collection Activities; Proposed Collection;
Comment Request; Recordkeeping Requirements for Microbiological Testing
and Corrective Measures for Bottled Water

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing an
opportunity for public comment on the proposed collection of certain
information by the agency. Under the Paperwork Reduction Act of 1995
(the PRA), Federal agencies are required to publish notice in the
Federal Register concerning each proposed collection of information and
to allow 60 days for public comment in response to the notice. This
notice solicits comments on the collection of information provisions of
the final rule, ``Beverages: Bottled Water,'' published elsewhere in
this issue of the Federal Register, which requires both domestic and
foreign bottled water manufacturers that sell bottled water in the
United States to maintain records of Escherichia coli testing and
corrective measures, in addition to existing recordkeeping
requirements.

DATES: Submit written or electronic comments on the collection of
information by July 28, 2009.

ADDRESSES: Submit electronic comments on the collection of information
to http://www.regulations.gov. Submit written comments on the
collection of information to the Division of Dockets Management (HFA-
305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061,
Rockville, MD 20852. All comments should be identified with the docket
number found in brackets in the heading of this document.

FOR FURTHER INFORMATION CONTACT: Jonna Capezzuto, Office of Information
Management (HFA-710), Food and Drug Administration, 5600 Fishers Lane,
Rockville, MD 20857,<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION: Under the PRA (44 U.S.C. 3501-3520), Federal
agencies must obtain approval from the Office of Management and Budget
(OMB) for each collection of information they conduct or sponsor.
``Collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests or requirements that members of
the public submit reports, keep records, or provide information to a
third party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A))
requires Federal agencies to provide a 60-day notice in the Federal
Register concerning each proposed collection of information before
submitting the collection to OMB for approval. To comply with this
requirement, FDA is publishing notice of the proposed collection of
information set forth in this document.
    With respect to the following collection of information, FDA
invites comments on these topics: (1) Whether the proposed collection
of information is necessary for the proper performance of FDA's
functions, including whether the information will have practical
utility; (2) the accuracy of FDA's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used; (3) ways to enhance the quality,
utility, and clarity of the information to be collected; and (4) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques, when
appropriate, and other forms of information technology.

Recordkeeping Requirements for Microbiological Testing and Corrective
Measures for Bottled Water--21 CFR 129.35(a)(3)(i), 129.80(g), and
129.80(h)

    FDA has amended its bottled water regulations in parts 129 and 165
(21 CFR parts 129 and 165) by requiring that if any coliform organisms
are detected in weekly total coliform testing of finished bottled
water, follow-up testing must be conducted to determine whether any of
the coliform organisms are E. coli. FDA also amended the adulteration
provision of the bottled water standard (Sec.  165.110(d)) to indicate
that finished product that tests positive for E. coli will be deemed
adulterated under section 402(a)(3) of the Federal Food, Drug, and
Cosmetic Act (21 U.S.C. 342(a)(3)). In addition, FDA amended the
Current Good Manufacturing Practices (CGMP) regulations for bottled
water in part 129 by requiring that source water from other than a
public water system (PWS) be tested at least weekly for total coliform.
If any coliform organisms are detected in the source water, the bottled
water manufacturers are required to determine whether any of the
coliform organisms are E. coli. Source water found to contain E. coli
is not considered water of a safe, sanitary quality and would be
unsuitable for bottled water production. Before a bottler may use
source water from a source that has tested positive for E. coli, a
bottler must take appropriate measures to rectify or otherwise
eliminate the cause of the contamination. A source previously found to
contain E. coli will be considered negative for E. coli after five
samples collected over a 24-hour period from the same sampling site are
tested and found to be E. coli negative.
    Description of Respondents: The respondents to this proposed
information collection are domestic and foreign bottled water
manufacturers that sell bottled water in the United States.
    FDA estimates the burden of this collection of information as
follows:

                               Table 1.--Estimated Annual Recordkeeping Burden\1\
----------------------------------------------------------------------------------------------------------------
                       No. of        Annual Frequency       Total Annual
 21 CFR Section    Recordkeepers     per Recordkeeping        Records       Hours  per Record     Total Hours
----------------------------------------------------------------------------------------------------------------
Sec.  Sec.        319 (bottlers                       6            1,914                 0.08                153
 129.35(a)(3)(i)   subject to
 and 129.80(h)     source water
                   and finished
                   product
                   testing)
----------------------------------------------------------------------------------------------------------------
Sec.  Sec.        2.5 (bottlers                       5               12                 0.08                  1
 129.35(a)(3)(i)   conducting
 and 129.80(h)     secondary
                   testing of
                   source water)
----------------------------------------------------------------------------------------------------------------
Sec.  Sec.        2.5 (bottlers                       3                7.5               0.25                  2
 129.35(a)(3)(i)   rectifying
 and 129.80(h)     contamination)
----------------------------------------------------------------------------------------------------------------
Sec.   129.80(g)  95 (bottlers                        3              285                 0.08                 23
 and (h)           testing
                   finished
                   product only)
----------------------------------------------------------------------------------------------------------------
Total Annual Burden                                                                                179
----------------------------------------------------------------------------------------------------------------
\1\There are no capital costs or operating costs associated with this collection of information.

    The current CGMP regulations already reflect the time and
associated recordkeeping costs for those bottlers that are required to
conduct microbiological testing of their source water, as well as total
coliform testing of their finished bottled water products. FDA
therefore concludes that any additional burden and costs in
recordkeeping based on the new testing requirements for source and
finished bottled water are negligible. FDA estimates that the labor
burden of keeping records of each test is about 5 minutes per test. FDA
also requires follow-up testing of source water and finished bottled
water products for E. coli when total coliform positives occur. FDA
expects that 319 bottlers that use sources other than PWSs may find a
total coliform positive sample about 3 times per year in source testing
and about 3 times in finished product testing, for a total of 153 hours
of recordkeeping. In addition to the 319 bottlers, about 95 bottlers
that use PWSs may find a total coliform positive sample about 3 times
per year in finished product testing, for a total of 23 hours of
recordkeeping. Upon finding a total coliform positive sample, bottlers
will then have to conduct a follow-up test for E. coli.
    FDA expects that recordkeeping for the follow-up test for E. coli
will also take about 5 minutes per test. As shown in table 1 of this
document, FDA expects that 2.5 bottlers per year will have to carry out
the additional E. coli testing, with a burden of 1 hour. These bottlers
will also have to keep records about rectifying the source
contamination, for a burden of 2 hours. For all expected total coliform
testing, E. coli testing, and source rectification, FDA estimates a
total burden of 179 hours. FDA bases its estimate on its experience
with the current CGMP regulations.

    Dated: May 18, 2009.
Jeffrey Shuren,
Associate Commissioner for Policy and Planning.
[FR Doc. E9-12493 Filed 5-26-09; 4:15 pm]
BILLING CODE 4160-01-S


[Federal Register Volume 77, Number 209 (Monday, October 29, 2012)]
[Notices]
[Page 65604]
[FR Doc No: 2012-26317]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

Notice of Opportunity for Public Comment on Surplus Property
Release at Harnett Regional Jetport, NC

AGENCY: Federal Aviation Administration (FAA), DOT.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Under the provisions of Title 49, U.S.C. 47153(c), notice is
being given that the FAA is considering a request from the Harnett
Regional Jetport Administrator to waive the requirement that
approximately 9.54 acres of airport property, located at the Harnett
Regional Jetport, be used for aeronautical purposes.

DATES: Comments must be received on or before November 28, 2012.

ADDRESSES: Comments on this notice may be mailed or delivered in
triplicate to the FAA at the following address: Atlanta Airports
District Office, Attn: Rusty Nealis, Program Manager, 1701 Columbia
Ave., Suite 2-260, Atlanta, GA 30337-2747.
    In addition, one copy of any comments submitted to the FAA must be
mailed or delivered to Barry Blevins, Airport Administrator, Harnett
Regional Jetport, at the following address: Harnett Regional Jetport,
PO Box 65, Lillington, NC 27546.

FOR FURTHER INFORMATION CONTACT: Rusty Nealis, Program Manager, Atlanta
Airports District Office, 1701 Columbia Ave., Campus Building, Suite 2-
260, Atlanta, GA 30337-2747,<PHONE_NUMBER>. The application may be
reviewed in person at this same location.

SUPPLEMENTARY INFORMATION: The FAA is reviewing a request by the
Harnett Regional Jetport Administrator to release approximately 9.54
acres of airport property at the Harnett Regional Jetport. The property
consists of one parcel located adjacent to the Harnett Regional Jetport
and between Airport Road and Old Stage Road. This property is currently
shown on the approved Airport Layout Plan as non-aeronautical use land
and the proposed use of this property is compatible with airport
operations. The County will sell the property for woodland or cropland
use with proceeds of the sale providing funding for future airport
development.
    Any person may inspect the request in person at the FAA office
listed above under FOR FURTHER INFORMATION CONTACT. In addition, any
person may, upon request, inspect the request, notice and other
documents germane to the request in person at the Harnett Regional
Jetport.

    Issued in Atlanta, Georgia on October 12, 2012.
Scott L. Seritt,
Manager, Atlanta Airports District Office, Southern Region.
[FR Doc. 2012-26317 Filed 10-26-12; 8:45 am]
BILLING CODE 4910-13-M


[Federal Register Volume 81, Number 4 (Thursday, January 7, 2016)]
[Proposed Rules]
[Page 733]
[FR Doc No: 2016-00044]

========================================================================
Proposed Rules
                                                Federal Register
________________________________________________________________________

This section of the FEDERAL REGISTER contains notices to the public of
the proposed issuance of rules and regulations. The purpose of these
notices is to give interested persons an opportunity to participate in
the rule making prior to the adoption of the final rules.

========================================================================

Federal Register / Vol. 81, No. 4 / Thursday, January 7, 2016 /
Proposed Rules

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

17 Part 240

[Release No. 34-76624A; File No. S7-26-15]
RIN 3235-AL72

Establishing the Form and Manner With Which Security-Based Swap
Data Repositories Must Make Security-Based Swap Data Available to the
Commission; Correction

AGENCY: Securities and Exchange Commission.

ACTION: Proposed rule; Correction.

-----------------------------------------------------------------------

SUMMARY: The Securities and Exchange Commission published a Proposed
Rule in the Federal Register on Wednesday, December 23, 2015 (FR Doc
2015-31703; 80 FR 79757) concerning, Establishing the Form and Manner
with which Security-Based Swap Data Repositories Must Make Security-
Based Swap Data Available to the Commission. The printed document
contained omitted information in the signatory block.

FOR FURTHER INFORMATION CONTACT: Crystal Pemberton, Office of the
Secretary, Securities and Exchange Commission, 100 F Street NE.,
Washington, DC 20549,<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION: On page 79773, in the third column add the
date of ``December 11, 2015'' to the signatory block.

Correction

    In the Federal Register of Wednesday, December 23, 2015, FR Doc
2015-31703, on page 79773, under PART 240--GENERAL RULES AND
REGULATIONS, SECURITIES EXCHANGE ACT OF 1934, in the third column,
after Sec.  240.13n-4 Duties and core principles of security-based swap
data repository, the following signature date of ``December 11, 2015''
is corrected to read before the signatory block.

Brent J. Fields,
Secretary.
[FR Doc. 2016-00044 Filed 1-6-16; 8:45 am]
BILLING CODE 8011-01-P


[Federal Register Volume 88, Number 163 (Thursday, August 24, 2023)]
[Notices]
[Pages 57952-57953]
[FR Doc No: 2023-18214]

=======================================================================
-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[FRL-11350-01-OAR]

Availability of Data on Allocations of Cross-State Air Pollution
Rule Allowances to Existing Electricity Generating Units

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice of data availability.

-----------------------------------------------------------------------

SUMMARY: Under the Cross-State Air Pollution Rule (CSAPR) trading
program regulations, EPA allocates emission allowances to existing
electricity generating units (EGUs) as provided in notices of data
availability (NODAs). Through this NODA, EPA is providing notice of the
availability of data on new or revised default allocations of CSAPR
NOX Ozone Season Group 3 allowances to existing units for
the 2023-2025 control periods, as well as the data upon which the
allocations are based.

DATES: August 24, 2023.

FOR FURTHER INFORMATION CONTACT: Garrett Powers, Clean Air Markets
Division, Office of Atmospheric Protection, Office of Air and
Radiation, U.S. Environmental Protection Agency, Mail Code 6204A, 1200
Pennsylvania Avenue NW, Washington, DC 20460; telephone:<PHONE_NUMBER>;
email: [email protected].

SUPPLEMENTARY INFORMATION: In the Good Neighbor Plan,\1\ EPA expanded
the CSAPR NOX Ozone Season Group 3 Trading Program \2\ to
include EGUs in 10 additional states and updated the program's
provisions to achieve further emissions reductions.\3\ The rule's
required emissions control stringencies are reflected in new or revised
state emissions budgets which in turn necessitate new or revised unit-
level allowance allocations. Beginning with the 2024 control period,
each covered state has the option to determine how the CSAPR
NOX Ozone Season Group 3 allowances in its state emissions
budget should be allocated among the state's units through a state
implementation plan (SIP) revision.\4\ However, for the 2023 control
period, and by default for subsequent control periods for which a state
has not provided EPA with the state's own allocations pursuant to an
approved SIP revision, the unit-level allocations are determined by
EPA.
---------------------------------------------------------------------------

    \1\ Federal ``Good Neighbor Plan'' for the 2015 Ozone National
Ambient Air Quality Standards, 88 FR 36654 (June 5, 2023).
    \2\ The CSAPR NOX Ozone Season Group 3 Trading
Program was originally established in the Revised CSAPR Update (86
FR 23054, April 30, 2021) as a mechanism for EGUs in 12 states to
reduce ozone season emissions of nitrogen oxides (NOX)
starting in 2021.
    \3\ Some courts have issued preliminary orders partially staying
the effectiveness of a separate EPA action (88 FR 9336, February 13,
2023) which disapproves state implementation plans addressing good
neighbor obligations for several states, and EPA is taking measures
to comply with those orders. The description of the Good Neighbor
Plan in this NODA reflects the rule as published, without regard to
the stay orders and the measures EPA is taking to comply with them.
However, EPA will not record allocations of CSAPR NOX
Ozone Season Group 3 allowances to any EGUs that are not currently
participating in the CSAPR NOX Ozone Season Group 3
Trading Program because of the measures EPA is taking to comply with
the stay orders. Consequently, the spreadsheet referenced in this
NODA has been edited to remove information on unit-level allocations
of CSAPR NOX Ozone Season Group 3 allowances to units in
any state covered by a stay order when the NODA was signed.
    \4\ See 40 CFR 52.38(b)(10) through (12).
---------------------------------------------------------------------------

    Under EPA's default unit-level allocation methodology for the Good
Neighbor Plan, most EGUs within a covered state's borders are treated
as ``existing'' units and receive allocations of allowances for a given
control period in advance of the control period.\5\ If any of the
existing units are located in areas of Indian country within the
state's borders that are not subject to the state's SIP authority, the
default allocations to those existing units are made through an
``Indian country existing unit set-aside'' in parallel with the default
allocations to the other existing units.\6\ The EGUs that EPA
identified in the rulemaking as eligible to receive default allocations
as existing units for the 2023-2025 control periods in the states
covered by this NODA are listed in the spreadsheet referenced later in
this notice. EGUs located anywhere within a state's borders that do not
receive allocations of CSAPR NOX Ozone Season Group 3
allowances as ``existing'' units and that report emissions subject to
allowance holding requirements for a given control period are eligible
to receive allowance allocations as ``new'' units from the state's new
unit set-aside for that control period.\7\
---------------------------------------------------------------------------

    \5\ See 40 CFR 97.1011.
    \6\ See 40 CFR 97.1010(b).
    \7\ See 40 CFR 97.1010(c) and 97.1012. Allocations from a
state's new unit set-aside for a given control period are made after
the respective control period and are not addressed in this notice.
---------------------------------------------------------------------------

    EPA determined new and revised state emissions budgets for the
2023-2025 control periods on a full-season basis in the Good Neighbor
Plan rulemaking. However, because the Agency anticipated that the
rule's effective date could fall after the start of the 2023 ozone
season, the final regulations include a procedure for prorating the
2023 state emissions budgets to ensure that the enhanced control
stringency reflected in the Good Neighbor Plan's full-season 2023 state
emissions budgets will apply only after the rule's effective date.\8\
The Good Neighbor Plan provided that the 2023 unit-level allocations
would be computed by applying the rule's unit-level allocation
methodology to the 2023 state emissions budgets determined through the
prorating procedure.\9\
---------------------------------------------------------------------------

    \8\ See 40 CFR 97.1010(a)(1)(ii).
    \9\ See 88 FR 36811-13.
---------------------------------------------------------------------------

    Through this NODA, EPA is providing notice of the availability of
data concerning the default unit-level allocations of CSAPR
NOX Ozone Season Group 3 allowances to existing units for
the 2023, 2024, and 2025 control periods. The allocations are shown in
an Excel spreadsheet entitled ``Unit-level Allocations and Underlying
Data for the Final Rule'' posted on

EPA's website at www.epa.gov/csapr/good-neighbor-plan-2015-ozone-naaqs.
The spreadsheet also contains the data upon which the allocations are
based, including the 2023 state emissions budgets that EPA has computed
according to the prorating procedure in the regulations. The
spreadsheet is an update of an earlier version included in the docket
for the final Good Neighbor Plan which showed the allocations for the
2024 and 2025 control periods as well as illustrative allocations for
the 2023 control period. All allocations have been determined according
to the allocation methodology finalized in the Good Neighbor Plan
rulemaking.\10\ EPA is not requesting comment on the allocations, the
underlying data, or the allocation methodology.
---------------------------------------------------------------------------

    \10\ See Allowance Allocation under the Final Rule TSD, EPA-HQ-
OAR-2021-0668-1079, available at www.regulations.gov and
www.epa.gov/csapr/good-neighbor-plan-2015-ozone-naaqs; see also 88
FR 36805-07.
---------------------------------------------------------------------------

    In accordance with the deadlines set forth in the regulations, EPA
will record allocations of CSAPR NOX Ozone Season Group 3
allowances to existing units for the 2023 control period by September
5, 2023.\11\ EPA will also record allocations to existing units for the
2024 control period by that same date except in instances where a state
has provided EPA with timely notice of the state's intent to submit a
SIP revision with state-determined allowance allocations replacing
EPA's default allocations for the 2024 control period.\12\ However, in
the case of any source that has not yet fully complied with the Good
Neighbor Plan's requirements concerning the recall of CSAPR
NOX Ozone Season Group 2 allowances allocated for control
periods after 2022, recordation of CSAPR NOX Ozone Season
Group 3 allowances will be deferred until the source has fully complied
with the recall requirements.\13\ EPA will record allocations of CSAPR
NOX Ozone Season Group 3 allowances to existing units for
the 2025 control period by July 1, 2024.\14\
---------------------------------------------------------------------------

    \11\ See 40 CFR 97.1021(d) and (g).
    \12\ See 40 CFR 97.1021(e).
    \13\ See 40 CFR 97.1021(m); see also 40 CFR 97.811(e).
    \14\ See 40 CFR 97.1021(f) and (h).
---------------------------------------------------------------------------

    EPA notes that an allocation or lack of allocation of emission
allowances to a given unit under a CSAPR trading program does not
constitute a determination that the trading program does or does not
apply to the unit.\15\ EPA also notes that allocations are subject to
potential correction or termination under the regulations.\16\
---------------------------------------------------------------------------

    \15\ See 40 CFR 97.1011(a)(3).
    \16\ See 40 CFR 97.1011(c).
---------------------------------------------------------------------------

    Authority: 40 CFR 97.1011(a)(1) and (2).

Rona Birnbaum,
Director, Clean Air Markets Division, Office of Atmospheric Protection,
Office of Air and Radiation.
[FR Doc. 2023-18214 Filed 8-23-23; 8:45 am]
BILLING CODE 6560-50-P


[Federal Register: March 1, 2007 (Volume 72, Number 40)]
[Notices]
[Page 9324]
[DOCID:fr01mr07-55]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. RP07-173-000]

Viking Gas Transmission Company; Notice of Tariff Filing

February 23, 2007.

    Take notice that on February 16, 2007, Viking Gas Transmission
Company (Viking) tendered for filing to be part of its FERC Gas Tariff,
First Revised Volume No. 1, Nineteenth Revised Sheet No. 5B, to become
effective April 1, 2007.
    Any person desiring to intervene or to protest this filing must
file in accordance with Rules 211 and 214 of the Commission's Rules of
Practice and Procedure (18 CFR 385.211 and 385.214). Protests will be
considered by the Commission in determining the appropriate action to
be taken, but will not serve to make protestants parties to the
proceeding. Any person wishing to become a party must file a notice of
intervention or motion to intervene, as appropriate. Such notices,
motions, or protests must be filed in accordance with the provisions of
Section 154.210 of the Commission's regulations (18 CFR 154.210).
Anyone filing an intervention or protest must serve a copy of that
document on the Applicant. Anyone filing an intervention or protest on
or before the intervention or protest date need not serve motions to
intervene or protests on persons other than the Applicant.
    The Commission encourages electronic submission of protests and
interventions in lieu of paper using the ``eFiling'' link at http://www.ferc.gov.
 Persons unable to file electronically should submit an

original and 14 copies of the protest or intervention to the Federal
Energy Regulatory Commission, 888 First Street, NE., Washington, DC
20426.
    This filing is accessible on-line at http://www.ferc.gov, using the

``eLibrary'' link and is available for review in the Commission's
Public Reference Room in Washington, DC. There is an ``eSubscription''
link on the Web site that enables subscribers to receive e-mail
notification when a document is added to a subscribed docket(s). For
assistance with any FERC Online service, please e-mail
<EMAIL_ADDRESS>or call<PHONE_NUMBER> (toll free). For

TTY, call<PHONE_NUMBER>.

Magalie R. Salas,
Secretary.
[FR Doc. E7-3599 Filed 2-28-07; 8:45 am]

BILLING CODE 6717-01-P


[Federal Register: November 21, 2007 (Volume 72, Number 224)]
[Proposed Rules]
[Page 65474-65476]
[DOCID:fr21no07-17]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

14 CFR Part 39

[Docket No. FAA-2007-0215; Directorate Identifier 2007-NM-216-AD]
RIN 2120-AA64

Airworthiness Directives; Bombardier Model CL-600-2B19 (Regional
Jet Series 100 & 440) Airplanes

AGENCY: Federal Aviation Administration (FAA), Department of
Transportation (DOT).

ACTION: Notice of proposed rulemaking (NPRM).

-----------------------------------------------------------------------

SUMMARY: The FAA proposes to supersede an existing airworthiness
directive (AD) that applies to certain Bombardier Model CL-600-2B19
(Regional Jet Series 100 & 440) airplanes. The existing AD currently
requires inspecting contactors 1K4XD, 2K4XD, and K4XA to determine the
type of terminal base plate, and applying sealant on the terminal base
plates if necessary. This proposed AD would require an inspection to
determine if certain alternating current (AC) service and utility bus
contactors have a terminal base plate made from non-G9 melamine
material, and corrective actions if necessary; or reidentification of
the mounting tray of the contactors; as applicable. This proposed AD
also limits the applicability of the existing AD. This proposed AD
results from incidents of short circuit failures of certain AC
contactors located in the avionics bay. We are proposing this AD to
prevent short circuit failures of certain AC contactors, which could
result in arcing and consequent smoke or fire.

DATES: We must receive comments on this proposed AD by December 21,
2007.

ADDRESSES: You may send comments by any of the following methods:
     Federal eRulemaking Portal: Go to http://www.regulations.gov.
 Follow the instructions for submitting comments.

     Fax:<PHONE_NUMBER>.
     Mail: U.S. Department of Transportation, Docket
Operations, M-30, West Building Ground Floor, Room W12-140, 1200 New
Jersey Avenue, SE., Washington, DC 20590.
     Hand Delivery: U.S. Department of Transportation, Docket
Operations, M-30, West Building Ground Floor, Room W12-140, 1200 New
Jersey Avenue, SE., Washington, DC 20590, between 9 a.m. and 5 p.m.,
Monday through Friday, except Federal holidays.
    For service information identified in this AD, contact Bombardier,
Inc., Canadair, Aerospace Group, P.O. Box 6087, Station Centre-ville,
Montreal, Quebec H3C 3G9, Canada.

Examining the AD Docket

    You may examine the AD docket on the Internet at http://www.regulations.gov
; or in person at the Docket Management Facility

between 9 a.m. and 5 p.m., Monday through Friday, except Federal
holidays. The AD docket contains this proposed AD, the regulatory
evaluation, any comments received, and other information. The street
address for the Docket Office (telephone<PHONE_NUMBER>) is in the
ADDRESSES section. Comments will be available in the AD docket shortly
after receipt.

FOR FURTHER INFORMATION CONTACT: Wing Chan, Aerospace Engineer, Systems
and Flight Test Branch, ANE-172, FAA, New York Aircraft Certification
Office, 1600 Stewart Avenue, suite 410, Westbury, New York 11590;
telephone<PHONE_NUMBER>; fax<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION:

Comments Invited

    We invite you to send any written relevant data, views, or
arguments about this proposed AD. Send your comments to an address
listed under the ADDRESSES section. Include ``Docket No. FAA-2007-0215;
Directorate Identifier 2007-NM-216-AD'' at the beginning of your
comments. We specifically invite comments on the overall regulatory,
economic, environmental, and energy aspects of this proposed AD. We
will consider all comments received by the closing date and may amend
this proposed AD because of those comments.
    We will post all comments we receive, without change, to http://www.regulations.gov
, including any personal information you provide. We

will also post a report summarizing each substantive verbal contact we
receive about this proposed AD.

Discussion

    On August 14, 2006, we issued AD 2006-17-14, amendment 39-14735 (71
FR 49337, August 23, 2006), for certain Bombardier Model CL-600-2B19
(Regional Jet Series 100 & 440) airplanes. That AD requires inspecting
contactors 1K4XD, 2K4XD, and K4XA to determine the type of terminal
base plate, and applying sealant on the terminal base plates, if
necessary. That AD resulted from incidents of short circuit failures of
certain alternating current (AC) contactors located in the avionics
bay. We issued that AD to prevent short circuit failures of certain AC
contactors, which could result in arcing and consequent smoke or fire.

Actions Since Existing AD Was Issued

    The preamble to AD 2006-17-14 explains that we consider the
requirements ``interim action'' and were considering further
rulemaking. We now have determined that further rulemaking is indeed
necessary, and this proposed AD follows from that determination.

Relevant Service Information

    Bombardier has issued Service Bulletin 601R-24-123, Revision B,
dated February 16, 2007. The service bulletin describes the following
actions, depending on the airplane configuration:
     Doing a visual inspection to determine if AC utility bus
contactors 1K4XD and 2K4XD, part number (P/N) D-18ZZA, and the AC
service bus contactor K4XA, P/N D-7GRZ, have a terminal base plate made
from non-G9 melamine material (Ultem 2200 material or black in color),
and doing applicable corrective actions. The corrective actions include
replacing damaged terminal lugs with new lugs, repairing or replacing
damaged wire with new wire, and replacing a certain AC service or
utility bus contactor with a new one; as applicable.
     Changing the service bulletin number on the mounting tray
of the contactors.
    Accomplishing the actions specified in the service information is
intended to adequately address the unsafe condition. Transport Canada
Civil Aviation (TCCA), which is the airworthiness authority for Canada,
mandated the service information and issued Canadian airworthiness
directive CF-2006-17R1, dated May 30, 2007, to ensure the continued
airworthiness of these airplanes in Canada.

FAA's Determination and Requirements of the Proposed AD

    These airplanes are manufactured in Canada and are type
certificated for operation in the United States under the provisions of
section 21.29 of the Federal Aviation Regulations (14 CFR 21.29) and
the applicable bilateral airworthiness agreement. Pursuant to this
bilateral airworthiness agreement, TCCA has kept the FAA informed of
the situation described above. We have examined TCCA's findings,
evaluated all pertinent information, and determined that AD action is
necessary for airplanes of this type design that are certificated for
operation in the United States.
    This proposed AD would supersede AD 2006-17-14 and would continue
to require inspecting contactors 1K4XD, 2K4XD, and K4XA to determine
the type of terminal base plate, and applying sealant on the terminal
base plates if necessary. This proposed AD also would require
accomplishing the actions specified in the service bulletin described
previously, which would constitute terminating action for the
requirements of this proposed AD.

Change to Existing AD

    AD 2006-17-14 affects Bombardier Model CL-600-2B19 (Regional Jet
Series 100 & 440) airplanes, certificated in any category; serial
numbers 7003 through 7990 inclusive and 8000 and subsequent. This
proposed AD would limit the applicability to those airplanes having
serial numbers 7003 through 7990 inclusive and 8000 through 8070
inclusive. This change parallels the applicability of the Canadian
airworthiness directive CF-2006-17R1.

Costs of Compliance

    The following table provides the estimated costs for U.S. operators
to comply with this proposed AD.

                                                                     Estimated Costs
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                Number of U.S.-
             Action                          Work hours              Average labor          Cost per airplane           registered        Fleet cost
                                                                     rate per hour                                       airplanes
--------------------------------------------------------------------------------------------------------------------------------------------------------
Inspection (required by AD 2006-  3...............................             $80  $240............................             739  $177,360.
 17-14).
New proposed actions (depending   1 or 2..........................              80  $80 or $160.....................             739  Between $59,120
 on the airplane configuration).                                                                                and $118,240.
--------------------------------------------------------------------------------------------------------------------------------------------------------

Authority for This Rulemaking

    Title 49 of the United States Code specifies the FAA's authority to
issue rules on aviation safety. Subtitle I, Section 106, describes the
authority of the FAA Administrator. Subtitle VII, Aviation Programs,
describes in more detail the scope of the Agency's authority.
    We are issuing this rulemaking under the authority described in
Subtitle VII, Part A, Subpart III, Section 44701, ``General
requirements.'' Under that section, Congress charges the FAA with
promoting safe flight of civil aircraft in air commerce by prescribing
regulations for practices, methods, and procedures the Administrator
finds necessary for safety in air commerce. This regulation is within
the scope of that authority because it addresses an unsafe condition
that is likely to exist or develop on products identified in this
rulemaking action.

Regulatory Findings

    We have determined that this proposed AD would not have federalism
implications under Executive Order 13132. This proposed AD would not
have a substantial direct effect on the States, on the relationship
between the national Government and the States, or on the distribution
of power and responsibilities among the various levels of government.
    For the reasons discussed above, I certify that the proposed
regulation:
    1. Is not a ``significant regulatory action'' under Executive Order
12866;
    2. Is not a ``significant rule'' under the DOT Regulatory Policies
and Procedures (44 FR 11034, February 26, 1979); and
    3. Will not have a significant economic impact, positive or
negative, on a substantial number of small entities under the criteria
of the Regulatory Flexibility Act.
    We prepared a regulatory evaluation of the estimated costs to
comply with this proposed AD and placed it in the AD docket. See the
ADDRESSES section for a location to examine the regulatory evaluation.

List of Subjects in 14 CFR Part 39

    Air transportation, Aircraft, Aviation safety, Safety.

The Proposed Amendment

    Accordingly, under the authority delegated to me by the
Administrator, the FAA proposes to amend 14 CFR part 39 as follows:

PART 39--AIRWORTHINESS DIRECTIVES

    1. The authority citation for part 39 continues to read as follows:

    Authority: 49 U.S.C. 106(g), 40113, 44701.

Sec.  39.13  [Amended]

    2. The Federal Aviation Administration (FAA) amends Sec.  39.13 by
removing amendment 39-14735 (71 FR 49337, August 23, 2006) and adding

the following new airworthiness directive (AD):

Bombardier, Inc. (Formerly Canadair): Docket No. FAA-2007-0215;
Directorate Identifier 2007-NM-216-AD.

Comments Due Date

    (a) The FAA must receive comments on this AD action by December
21, 2007.

Affected ADs

    (b) This AD supersedes AD 2006-17-14.

Applicability

    (c) This AD applies to Bombardier Model CL-600-2B19 (Regional
Jet Series 100 & 440) airplanes, certificated in any category;
serial numbers 7003 through 7990 inclusive, and 8000 through 8070
inclusive.

Unsafe Condition

    (d) This AD results from incidents of short circuit failures of
certain alternating current (AC) contactors located in the avionics
bay. We are issuing this AD to prevent short circuit failures of
certain AC contactors, which could result in arcing and consequent
smoke or fire.

Compliance

    (e) You are responsible for having the actions required by this
AD performed within the compliance times specified, unless the
actions have already been done.

Requirements of AD 2006-17-14

Inspection and Corrective Action

    (f) Within 800 flight hours or four months after September 7,
2006 (the effective date of AD 2006-17-14), whichever occurs first:
Do a general visual inspection of AC bus contactors 1K4XD and 2K4XD,
part number (P/N) D-18ZZA, and the bus contactor K4XA, P/N D-7GRZ,
to determine which contactors have an Ultem 2200 terminal base plate
(i.e., the plate is made from a black molded thermal plastic
material), and apply RTV sealant to the terminal base plate, as
applicable, by doing all the actions specified in the Accomplishment
Instructions of Bombardier Service Bulletin 601R-24-122, Revision A,
dated July 13, 2006. Do all applicable applications of sealant
before further flight.

    Note 1: For the purposes of this AD, a general visual inspection
is: ``A visual examination of an interior or exterior area,
installation, or assembly to detect obvious damage, failure, or
irregularity. This level of inspection is made from within touching
distance unless otherwise specified. A mirror may be necessary to
ensure visual access to all surfaces in the inspection area. This
level of inspection is made under normally available lighting
conditions such as daylight, hangar lighting, flashlight, or
droplight and may require removal or opening of access panels or
doors. Stands, ladders, or platforms may be required to gain
proximity to the area being checked.''

Previous Actions Accomplished According to Other Service
Information

    (g) Actions accomplished before September 7, 2006, in accordance
with Bombardier Drawing Number K601R50180, dated June 2, 2006; or
Bombardier Service Bulletin 601R-24-122, dated June 27, 2006; are
considered acceptable for compliance with the actions specified in
paragraph (f) of this AD.

New Requirements of This AD

Inspection and Corrective Action

    (h) Within 12 months after the effective date of this AD, do a
general visual inspection, reidentification, and corrective actions,
as applicable, by doing all the applicable actions specified in the
Accomplishment Instructions of Bombardier Service Bulletin 601R-24-
123, Revision B, dated February 16, 2007. Do the applicable
corrective action before further flight. Accomplishment of these
actions constitutes terminating action for the requirements of this
AD.

Parts Installation

    (i) As of the effective date of this AD, no person may install
any AC contactor 1K4XD, 2K4XD, or K4XA, having a non-G9 melamine
terminal base plate, on any airplane.

Alternative Methods of Compliance (AMOCs)

    (j)(1) The Manager, New York Aircraft Certification Office, FAA,
has the authority to approve AMOCs for this AD, if requested in
accordance with the procedures found in 14 CFR 39.19.
    (2) To request a different method of compliance or a different
compliance time for this AD, follow the procedures in 14 CFR 39.19.
Before using any approved AMOC on any airplane to which the AMOC
applies, notify your appropriate principal inspector (PI) in the FAA
Flight Standards District Office (FSDO), or lacking a PI, your local
FSDO.

Related Information

    (k) Canadian airworthiness directive CF-2006-17R1, dated May 30,
2007, also addresses the subject of this AD.

    Issued in Renton, Washington, on November 13, 2007.
Ali Bahrami,
Manager, Transport Airplane Directorate, Aircraft Certification
Service.
 [FR Doc. E7-22726 Filed 11-20-07; 8:45 am]

BILLING CODE 4910-13-P


[Federal Register: October 16, 2009 (Volume 74, Number 199)]
[Notices]
[Page 53270-53271]
[DOCID:fr16oc09-82]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket Nos. FDA-2009-M-0299, FDA-2009-M-0300, FDA-2009-M-0182, FDA-
2009-M-0244, FDA-2009-M-0243, FDA-2009-M-0255]

Medical Devices; Availability of Safety and Effectiveness
Summaries for Premarket Approval Applications

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is publishing a list of
premarket approval applications (PMAs) that have been approved. This
list is intended to inform the public of the availability of safety and
effectiveness summaries of approved PMAs through the Internet and the
agency's Division of Dockets Management.

ADDRESSES: Submit written requests for copies of summaries of safety
and effectiveness data to the Division of Dockets Management (HFA-305),
Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville,
MD 20852. Please cite the appropriate docket number as listed in Table
1 of this document when submitting a written request. See the
SUPPLEMENTARY INFORMATION section for electronic access to the
summaries of safety and effectiveness.

FOR FURTHER INFORMATION CONTACT: Nicole Wolanski, Center for Devices
and Radiological Health, Food and Drug Administration, 10903 New
Hampshire Ave., Bldg. 66, rm. 1650, Silver Spring, MD 20993, 301-796-
6570.

SUPPLEMENTARY INFORMATION:

I. Background

    In the Federal Register of January 30, 1998 (63 FR 4571), FDA
published a final rule that revised 21 CFR 814.44(d) and 814.45(d) to
discontinue individual publication of PMA approvals and denials in the
Federal Register. Instead, the agency now posts this information on the
Internet on FDA's home page at http://www.fda.gov. FDA believes that
this procedure expedites public notification of these actions because
announcements can be placed on the Internet more quickly than they can
be published in the Federal Register, and FDA believes that the
Internet is accessible to more people than the Federal Register.
    In accordance with section 515(d)(4) and (e)(2) of the Federal
Food, Drug, and Cosmetic Act (the act) (21 U.S.C. 360e(d)(4) and
(e)(2)), notification of an order approving, denying, or withdrawing
approval of a PMA will continue to include a notice of opportunity to
request review of the order under section 515(g) of the act. The 30 day
period for requesting reconsideration of an FDA action under Sec.
10.33(b) (21 CFR 10.33(b)) for notices announcing approval of a PMA
begins on the day the notice is placed on the Internet. Section
10.33(b) provides that FDA may, for good cause, extend this 30 day
period. Reconsideration of a denial or withdrawal of approval of a PMA
may be sought only by the applicant; in these cases, the 30 day period
will begin when the applicant is notified by FDA in writing of its
decision.
    The regulations provide that FDA publish a quarterly list of
available safety and effectiveness summaries of PMA approvals and
denials that were announced during that quarter. The following is a
list of approved PMAs for which summaries of safety and effectiveness
were placed on the Internet from April 1, 2009, through June 30, 2009.
There were no denial actions during this period. The list provides the
manufacturer's name, the product's generic name or the trade name, and
the approval date.

 Table 1.--List of Safety and Effectiveness Summaries for Approved PMAs
        Made Available From April 1, 2009, through June 30, 2009.
------------------------------------------------------------------------
 PMA No./Docket                                                Approval
       No.           Applicant             TRADE NAME            Date
------------------------------------------------------------------------
P080014           Third Wave       CERVISTA HPV HR            March 12,
FDA-2009-M-0299    Technologies,                               2009
                   Inc.
------------------------------------------------------------------------
P080015           Third Wave       CERVISTA HPV 16/18         March 12,
FDA-2009-M-0300    Technologies,                               2009
                   Inc.
------------------------------------------------------------------------
P080006           Medtronic Inc.   MEDTRONIC ATTAIN ABILITY   April 7,
FDA-2009-M-0182                     MODEL 4196 LEAD            2009
------------------------------------------------------------------------
P080023            Abbott          ARCHITECT CORE REAGENT     April 10,
FDA-2009-M-0244    Laboratories     KIT, ARCHITECT CORE        2009
                                    CALIBRATOR AND ARCHITECT
                                    CORE CONTROLS
------------------------------------------------------------------------
P060023           Medtronic        BRYAN CERVICAL DISC        May 12,
FDA-2009-M-0243    Sofamor Danek                               2009
------------------------------------------------------------------------
P060008 (S8)      Boston           TAXUS LIBERTE ATOM         May 21,
FDA-2009-M-0255    Scientific Co.   PACLITAXEL-ELUTING         2009
                                    CORONARY STENT SYSTEM
------------------------------------------------------------------------

II. Electronic Access

    Persons with access to the Internet may obtain the documents at
http://www.fda.gov/cdrh/pmapage.html.

    Dated: October 2, 2009.
Jeffrey Shuren,
Acting Director, Center for Devices and Radiological Health.
[FR Doc. E9-24967 Filed 10-15-09; 8:45 am]

BILLING CODE 4160-01-S


[Federal Register Volume 86, Number 197 (Friday, October 15, 2021)]
[Notices]
[Pages 57421-57422]
[FR Doc No: 2021-22521]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Project No. 15045-000]

Current Hydro Project 19, LLC; Notice of Intent To File License
Application, Filing of Pre-Application Document, Approving Use of the
Traditional Licensing Process

    a. Type of Filing: Notice of Intent to File License Application and
Request to Use the Traditional Licensing Process.
    b. Project No.: P-15045-000.
    c. Date Filed: August 11, 2021.
    d. Submitted By: Current Hydro Project 19, LLC (Current Hydro 19).
    e. Name of Project: New Cumberland Locks and Dam Hydroelectric
Project.
    f. Location: At the U.S. Army Corps of Engineers' (Corps) New
Cumberland Locks and Dam on the Ohio River in Hancock County, West
Virginia and Jefferson County, Ohio. The project would occupy federal
land administered by the Corps.
    g. Filed Pursuant to: 18 CFR 5.3 of the Commission's regulations.
    h. Potential Applicant Contact: Mr. Joel Herm, P.O. Box 224,
Rhinebeck, NY 12572-0224;<PHONE_NUMBER>; [email protected].
    i. FERC Contact: Jody Callihan at<PHONE_NUMBER>, or at
[email protected].
    j. Current Hydro 19 filed its request to use the Traditional
Licensing Process on August 11, 2021 and provided public notice of its
request on the same date. In a letter dated October 8, 2021, the
Director of the Division of Hydropower Licensing approved Current Hydro
19's request to use the Traditional Licensing Process.
    k. With this notice, we are initiating informal consultation with
the U.S. Fish and Wildlife Service and/or NOAA Fisheries under section
7 of the Endangered Species Act and the joint agency regulations
thereunder at 50 CFR, Part 402; and NOAA Fisheries under section 305(b)
of the Magnuson-Stevens Fishery Conservation and Management Act and
implementing regulations at 50 CFR 600.920. We are also initiating
consultation with the West Virginia and Ohio State Historic
Preservation Officers, as required by section 106, National Historic
Preservation Act, and the implementing regulations of the Advisory
Council on Historic Preservation at 36 CFR 800.2.
    l. With this notice, we are designating Current Hydro 19 as the
Commission's non-federal representative for carrying out informal
consultation pursuant to section 7 of the Endangered Species Act; and
consultation pursuant to section 106 of the National Historic
Preservation Act.
    m. Current Hydro 19 filed a Pre-Application Document (PAD;
including a proposed process plan and schedule) with the Commission,
pursuant to 18 CFR 5.6 of the Commission's regulations.
    n. A copy of the PAD may be viewed and/or printed on the
Commission's website (http://www.ferc.gov), using the ``eLibrary''
link. Enter the docket number, excluding the last three digits in the
docket number field to access the document. At this time, the
Commission

has suspended access to the Commission's Public Reference Room, due to
the proclamation declaring a National Emergency concerning the Novel
Coronavirus Disease (COVID-19), issued on March 13, 2020. For
assistance, contact FERC Online Support at [email protected],
(866) 208-3676 (toll free), or<PHONE_NUMBER> (TTY). Register online at
https://ferconline.ferc.gov/FERCOnline.aspx to be notified via email of
new filings and issuances related to this or other pending projects.
For assistance, contact FERC Online Support.

    Dated: October 8, 2021.
Kimberly D. Bose,
Secretary.
[FR Doc. 2021-22521 Filed 10-14-21; 8:45 am]
BILLING CODE 6717-01-P


[Federal Register Volume 83, Number 234 (Thursday, December 6, 2018)]
[Notices]
[Page 62876]
[FR Doc No: 2018-26420]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HOMELAND SECURITY

Coast Guard

[Docket No. USCG-2018-0876]

Merchant Marine Personnel Advisory Committee; Vacancies

AGENCY: U.S. Coast Guard, Department of Homeland Security.

ACTION: Request for applications.

-----------------------------------------------------------------------

SUMMARY: The U.S. Coast Guard seeks applications for membership on the
Merchant Marine Personnel Advisory Committee. This Committee acts
solely in an advisory capacity to the Secretary of the Department of
Homeland Security through the Commandant of the U.S. Coast Guard on
matters relating to personnel in the United States merchant marine,
including training, qualifications, certification, documentation, and
fitness standards and other matters as assigned by the Commandant. The
Committee advises, consults with, and makes recommendations reflecting
its independent judgment to the Secretary and may make available to
Congress recommendations that the Committee makes to the Secretary. In
addition, the committee may be given special assignments by the
Secretary and may conduct studies, inquiries, workshops, and fact
finding in consultation with individuals and groups in the private
sector and with State or local governments.

DATES: Completed applications should be submitted to the U.S. Coast
Guard on or before February 4, 2019.

ADDRESSES: Applicants should send a cover letter expressing interest in
an appointment to the Merchant Marine Personnel Advisory Committee that
identifies the applicant's preferred membership category along with a
resume detailing the applicant's experience by one of the following
methods:
     By Email: [email protected], (preferred)
Subjectline: The Merchant Marine Personnel Advisory Committee;
     By Fax:<PHONE_NUMBER> ATTN: Mr. Davis J. Breyer, Alternate
Designated Federal Officer; or
     By Mail: Mr. Davis J. Breyer, Alternate Designated Federal
Officer of the Merchant Marine Personnel Advisory Committee, Commandant
(CG-MMC-1)/MERPAC, U.S. Coast Guard, 2703 Martin Luther King Jr. Ave
SE, Stop 7509, Washington, DC 20593-7509.

FOR FURTHER INFORMATION CONTACT: Mr. Davis J. Breyer, Alternate
Designated Federal Officer of the Merchant Marine Personnel Advisory
Committee, Commandant, (CG-MMC-1)/MERPAC, U.S. Coast Guard, 2703 Martin
Luther King Jr. Ave SE, Stop 7509, Washington, DC 20593-7509, telephone
202-372-1445, fax<PHONE_NUMBER> or [email protected].

SUPPLEMENTARY INFORMATION: The Merchant Marine Personnel Advisory
Committee is a federal advisory committee established in accordance
with the provisions of the Federal Advisory Committee Act (Title 5
U.S.C. Appendix) and 46 U.S.C. 8108.
    The Committee meets at least twice each year. Its subcommittees and
working groups may hold additional meetings as needed to consider
specific tasks.
    Each Committee member serves a term of office of up to three years.
Members may serve a maximum of two consecutive terms. All members serve
at their own expense and receive no salary or other compensation from
the Federal Government. Members may be reimbursed for travel and per
diem in accordance with Federal Travel Regulations.
    We will consider applications for the following four positions that
will be vacant on June 1, 2019. To be eligible, you must have the
experience listed for the applicable membership position:
    (1) One position for a member who serves as a representative of
merchant marine engineering officers. To be eligible, you must be
licensed as either a limited chief engineer or a designated duty
engineer;
    (2) One position for a member who serves as a representative of
qualified members of the engine department. To be eligible, you must
hold a current merchant mariner credential with an engineering rating
endorsement;
    (3) One position for a member who serves as a representative of
shipping companies employed in ship operation management. To be
eligible, you must show that you have significant knowledge and
experience of shipping companies and ship operation management; and
    (4) One position for a member who serves as a representative of the
state maritime academies, as identified in 46 CFR 310 subpart A. To be
eligible, you must be jointly recommended by such state maritime
academies.
    Each member will be appointed as Representative, and are not
appointed in their individual capacity.
    The Department of Homeland Security does not discriminate in the
selection of Committee members on the basis of race, color, religion,
sex, national origin, political affiliation, sexual orientation, gender
identity, marital status, disabilities and genetic information, age,
membership in an employee organization, or any other non-merit factor.
The Department of Homeland Security strives to achieve a widely diverse
candidate pool for all of its recruitment actions.
    If you are interested in applying to become a member of the
Committee, send your cover letter and resume to Mr. Davis J. Breyer,
Alternate Designated Federal Officer of the Merchant Marine Personnel
Advisory Committee via one of the transmittal methods in the ADDRESSES
section by the deadline in the DATES section of this notice. All email
submittals will receive email receipt confirmations.

    Dated: November 29, 2018.
Jeffrey G. Lantz,
Director of Commercial Regulations and Standards.
[FR Doc. 2018-26420 Filed 12-4-18; 8:45 am]
BILLING CODE 9110-04-P